title: [EVALUATION OF THE HUMAN SENSITIVITY TO SMALLPOX VIRUS BY THE PRIMARY CULTURES OF THE MONOCYTE-MACROPHAGES].
abstract: Studies of the primary cultures of granulocytes, mononuclear, and monocyte-macrophage cells derived from human blood were performed using variola virus (VARV) in the doses of 0.001-0.021 PFU/cell (plaques-forming units per cell). Positive dynamics of the virus accumulation was observed only in the monocyte-macrophages with maximum values of virus concentration (5.0-5.5 Ig PFU/ml) mainly within six days after the infection. The fact of VARV replication in the monocyte-macrophages was confirmed by the data of electron microscopy. At the same time, virus vaccines when tested in doses 3.3 and 4.2 Ig PFU/ml did not show the ability to reproduce in these human cells. The people sensitivity to VARV as assessed from the data obtained on human monocyte-macrophages corresponded to -1 PFU (taking into account the smooth interaction of the virus in the body to the cells of this type), which is consistent to previously found theoretical data on the virus sensitivity. The human susceptibility to VARV assessed experimentally can be used to predict the adequacy of developed smallpox models (in vivo) based on susceptible animals. This is necessary for reliable assessment of the efficiency of development of drugs for treatment and prophylaxis of the smallpox.
authors.forename: A S
authors.initials: AS
authors.lastname: Zamedyanskaya
authors.forename: K A
authors.initials: KA
authors.lastname: Titova
authors.forename: Al A
authors.initials: AA
authors.lastname: Sergeev
authors.forename: A S
authors.initials: AS
authors.lastname: Kabanov
authors.forename: L E
authors.initials: LE
authors.lastname: Bulychev
authors.forename: Ar A
authors.initials: AA
authors.lastname: Sergeev
authors.forename: D O
authors.initials: DO
authors.lastname: Galakhova
authors.forename: A E
authors.initials: AE
authors.lastname: Nesterov
authors.forename: O V
authors.initials: OV
authors.lastname: Nosareva
authors.forename: L N
authors.initials: LN
authors.lastname: Shishkina
authors.forename: O S
authors.initials: OS
authors.lastname: Taranov
authors.forename: V V
authors.initials: VV
authors.lastname: Omigov
authors.forename: A P
authors.initials: AP
authors.lastname: Agafonov
authors.forename: A N
authors.initials: AN
authors.lastname: Sergeev
mesh_terms: D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D006098:Granulocytes / Q000276:immunology; D006801:Humans; D008264:Macrophages / Q000648:ultrastructure / Q000821:virology*; D008297:Male; D008854:Microscopy, Electron; D009928:Organ Specificity; D061251:Primary Cell Culture; D012899:Smallpox / Q000097:blood / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D012900:Smallpox Vaccine / Q000494:pharmacology; D012901:Variola virus / Q000502:physiology* / Q000648:ultrastructure; D014771:Virion / Q000254:growth & development* / Q000648:ultrastructure; D014779:Virus Replication
chemical_list: D000914:Antibodies, Viral; D012900:Smallpox Vaccine